Nexentis Technologies Inc. NXTS
2.11 USD +0.05 (+2.43%)
Nov 13, 2026, 2:56 PM EST
2.06 Day range 2.22
2.01 52-week range 112.70
- YTD
- -96.41%
- 1 year
- -98.08%
News
benzinga.com Nexentis Technologies Announces 1-For-5 Reverse Stock Split, Effective November 9 The Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol "NXTS." As previously disclosed, at the Special Meeting of the Stockholders of Nexentis held on April…
benzinga.com 12 Materials Stocks Moving In Monday's After-Market Session Gainers Apex Critical Metals (NASDAQ:APXC) stock increased by 24.9% to $6.56 during Monday's after-market session. Paramount Gold Nevada (AMEX:PZG) shares moved upwards by 12.54% to $1.05. The…
benzinga.com Nexentis Technologies' MitoCareX Bio Subsidiary Completes Initial Computational Screening Stage Under Its Drug-Discovery Initiative With Boltz Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nexentis" or the "Company") today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX"), has completed an initial computational
benzinga.com Nexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On Google Cloud Platform The transition is designed to provide MitoCareX with a secure and flexible computing environment for its computational activities and evolving drug discovery requirements. The infrastructure…
benzinga.com Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Select Candidate For A Drug Discovery Campaign As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport proteins outside its mitochondrial program that appeared compatible with the MITOLINE® enabled…
benzinga.com Nexentis Technologies Subsidiary Completes Analysis Of SLC Transport Proteins, Starts Global AI Drug Discovery Initiative With Boltz Nexentis Technologies Inc. ("Nexentis"), (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business
benzinga.com Nexentis Technologies Amends Its Loan And Partnership Agreement With Solterra Renewable Energy, Other Lenders For Melz Solar Project; Solterra To Make Early Partial Repayments Of ~$147K On Its Part Of Loan, $98K For Sale Of 10% Of Its Profit Rights; Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today…
benzinga.com Crude Oil Down Over 1%; US Manufacturing PMI Surges In June US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer staples up 1.4%, tech down 2.3%. S&P PMI rises.
benzinga.com Dow Falls Over 300 Points; Korn Ferry Earnings Top Views US stocks down as Dow falls 300 points, while S&P 500 and NASDAQ also decrease. Consumer staples rise, tech stocks fall. Korn Ferry beats earnings.
benzinga.com Nexentis Technologies Soars 156% Before Falling 46% After Hours — Here’s Why NXTS Stock Is Trending Nexentis stock surged on AI drug discovery news before falling after announcing a $2.9 million offering.
benzinga.com Crude Oil Falls Over 2%; Getty Images Shares Spike Higher U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Monday. The Dow traded up 0.28% to 51,709.06 while the NASDAQ fell 1.31% to 26,170.77. The…
benzinga.com Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results US stocks rise, Dow up over 200 points. Financial shares jump 0.9% while communication services stocks fall 2.3%. Nexentis Technologies Inc shares surge 208%.
benzinga.com Nexentis Technologies Subsidiary MitoCareX Bio Partners With AI Biomolecular Drug Discovery Research Lab Boltz To Accelerate Identification Of Novel Small-Molecule Scaffolds Targeting Selected Solute Carrier Proteins Under this initiative, MitoCareX intends to combine two complementary and independently validated capabilities: MitoCareX’s proprietary MITOLINE® algorithm platform and Boltz’s foundation models for…
benzinga.com Nexentis Technologies Subsidiary Completes Structural Analysis Of Human Solute Carrier Transport Protein Nexentis Technologies Inc. (NASDAQ:NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today…
benzinga.com Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expected results and announcing a $300 million share buyback.
benzinga.com Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open. Other gainers include SLBT, TDIC, IMCC, IVDA, NXTS, CRVO, PAVS, ALBT, and PURR. Losers include…